RBR-8nfx26尚未招募2 期
Inhaled Nitric Oxide for Treatment of SARS-CoV-2 Infection: An Open-Label, Multicenter, Parallel, Randomized Controlled Trial
Pontifícia Universidade Católica do Rio Grande do Sul - PUCRS0 个研究点开始时间: 2020年9月22日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 10 至 100（—）
入选标准
- •Hospitalized patients with proven or high suspicion of coronavirus infection; signing a consent form and/or assent; older than 10 years. Score clinical 4 (receiving supplemental oxygen).
- •Non hospitalized patients with proven or high suspicion of coronavirus infection; signing a consent form and/or assent; older than 10 years. Score clinical 2 (at home with limitations).
排除标准
- •Participant in any other clinical trial of an experimental treatment for COVID-19; pregnancy; clinical contraindication of the attending physician; use of a nitric oxide donor agent, such as nitroglycerin or drugs known to increase methaemoglobin, such as lidocaine, prilocaine, benzocaine or dapsone; heart failure, left ventricular dysfunction; history of hemoptysis.
- •Participant in any other clinical trial of an experimental treatment for COVID-19; Pregnancy; clinical contraindication of the attending physician; indication for hospitalization at the time of evaluation; use of a nitric oxide donor agent, such as nitroglycerin or drugs prepared by increasing methemoglobin, such as lidocaine, prilocaine, benzocaine, or dapsone; heart failure, left ventricular dysfunction; hx of hemoptysis.
研究者
相似试验
已完成
2 期
Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19SARS (Severe Acute Respiratory Syndrome)CoronavirusNCT04306393Massachusetts General Hospital200
进行中（未招募）
1 期
Pulsed, inhaled nitric oxide (iNO) for the treatment of patients with mild ormoderate corona virus disease (COVID-19)EUCTR2020-002394-94-BEDr. De Backer Wilfried BV6
进行中（未招募）
1 期
Therapy with Inhaled Nitric Oxide for Patients Infected with Coronavirus Suffering form Lung FailureARDS caused by COVID-19 infectionEUCTR2020-001329-30-ATMassachussetts General Hospital200
进行中（未招募）
1 期
Inhaled Nitric Oxide Gas Therapy in Respiratory Treated Patients with COVID-19 infectioCOVID-19 infection caused by SARS-CoV-2MedDRA version: 20.0Level: LLTClassification code 10038700Term: Respiratory infectionSystem Organ Class: 100000004862EUCTR2020-001490-68-SEStockholm County Council; Danderyd Hospital40
已完成
1 期
High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients)COVID-19NCT04383002University Health Network, Toronto21